✦ LIBER ✦

Beneficial effect of ribavirin on hepatitis C-associated cryoglobulinemia after liver transplantation

✍ Scribed by Safadi, Rifaat ;Shouval, Daniel ;Kaspa, Ran Tur ;Ashur, Yaffa ;Ilan, Yaron

Publisher: Wiley (John Wiley & Sons)
Year: 1996
Tongue: English
Weight: 587 KB
Volume: 2
Category: Article
ISSN: 1074-3022
DOI: 10.1002/lt.500020403

No coin nor oath required. For personal study only.

✦ Synopsis

Mixed cryoglobulinemia is a well-known complication after hepatitis C virus (HCV) infection. We report five cases in which cryoglobulinemia appeared or grossly exacerbated following orthotopic liver transplantation (OLT). Cryoglobulinemia and the associated clinical symptoms resolved or improved in two patients treated with ribavirin after liver transplantation, while plasmapheresis was ineffective in another patient. The mechanism involved in induction of cryoglobulinemia after liver transplantation is unknown. However, the effect of antiviral therapy observed in these patients suggests a correlation between cryoglobulinemia, HCV replication, and possibly hepatocellular disease activity. A larger-scale study is warranted to test the effect of ribavirin on post-OLT HCV-associated cryoglobulinemia.

📜 SIMILAR VOLUMES

Prevalence of hepatitis C virus–associat

Prevalence of hepatitis C virus–associated mixed cryoglobulinemia after liver transplantation

✍ Gregory A. Abrahamian; A. Benedict Cosimi; Mary Lin Farrell; David A. Schoenfeld 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Hepatitis C virus (HCV) infection is associated with mixed cryoglobulinemia and membranoproliferative glomerulonephritis. After orthotopic liver transplantation (OLT), isolated cases of HCV-associated mixed cryoglobulinemia have been reported. We determined the prevalence and clinical characteristic

Recurrent hepatitis C after liver transp

Recurrent hepatitis C after liver transplantation: On-treatment prediction of response to peginterferon/ribavirin therapy

✍ Ibrahim A. Hanouneh; Charles Miller; Federico Aucejo; Rocio Lopez; Mary Kay Quin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 2 views

Sustained virologic response (SVR) in the treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation (LT) remains suboptimal. We evaluated efficacy of pegylated interferon alfa (PEG) and ribavirin (RBV) (PEG/RBV) combination therapy in LT recipients with recurrent HCV and p

Beneficial effect of phlebotomy on hepat

Beneficial effect of phlebotomy on hepatitis C virus-associated musculoskeletal manifestations

✍ N. Hilzenrat; D. Buskila; D. Zilberman; E. Sikuler 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 260 KB

Effects of double-filtration plasmaphere

Effects of double-filtration plasmapheresis combined with interferon plus ribavirin for recurrent hepatitis C after living donor liver transplantation

✍ Yasutsugu Takada; Takashi Ito; Yoshihide Ueda; Hironori Haga; Hiroto Egawa; Koic 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Response rates to interferon and ribavirin treatment for recipients with recurrent hepatitis C virus (HCV) infection are suboptimal, particularly for those with genotype 1b and high viral load. The present study evaluated the effects of combining double-filtration plasmapheresis (DFPP) with pharmaco

Predictors of survival after liver trans

Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C

✍ Mitsugi Shimoda; Rafik M. Ghobrial; Ian C. Carmody; Dean M. Anselmo; Douglas G. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

The efficacy of orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC) associated with hepatitis C virus (HCV) is not well defined. This study examines the variables that may determine the outcome of OLT for HCC in HCV patients. From 1990 to 1999, 463 OLTs were performed for HCV c

Clinical and histological efficacy of pe

Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation

✍ Inmaculada Fernández; Juan Carlos Meneu; Francisco Colina; Ignacio García; Raque 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

Treatment of recurrent hepatitis C in liver transplant is controversial. The aim of our study was to evaluate the clinical and histological efficacy of pegylated interferon alpha 2b (PEG-IFN) and ribavirin therapy of recurrent hepatitis C after liver transplantation (LT). We prospectively included 4